Aerie Pharmaceuticals reported $34.66M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Alimera Sciences ALIM:US $ 8.56M 128K
Amarin AMRN:US 102.96M 4.24M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Cara Therapeutics CARA:US $ 5.88M 262K
Coherus Biosciences CHRS:US $ 39.92M 420K
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Horizon Pharma HZNP:US 360.26M 5.06M
Insmed INSM:US $ 60.28M 3.1M
JAZZ PHA JAZZ:US 363.68M 65.35M
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Novartis NOVN:VX 3.6B 109M
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Supernus Pharmaceuticals SUPN:US $ 72.03M 2.5M
Teva Pharmaceutical Industries TEVA:US 864M 32M
Valeant Pharmaceuticals VRX:CN C$ 653M 32M
Zoetis ZTS:US $ 504M 9M
Zogenix ZGNX:US $ 39.56M 5.68M